231 related articles for article (PubMed ID: 22938157)
1. Systematized epidermal nevus with epidermolytic hyperkeratosis improving with topical calcipotriol/betametasone dipropionate combination ointment.
Koh MJ; Lee JS; Chong WS
Pediatr Dermatol; 2013; 30(3):370-3. PubMed ID: 22938157
[TBL] [Abstract][Full Text] [Related]
2. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
Claréus BW; Houwing R; Sindrup JH; Wigchert S
Eur J Dermatol; 2009; 19(6):581-5. PubMed ID: 19726275
[TBL] [Abstract][Full Text] [Related]
3. Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.
Girolomoni G; Vena GA; Ayala F; Cannavò SP; De Pità O; Chimenti S; Peserico A
G Ital Dermatol Venereol; 2012 Dec; 147(6):609-24. PubMed ID: 23149707
[TBL] [Abstract][Full Text] [Related]
4. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
Rigopoulos D; Gregoriou S; Daniel Iii CR; Belyayeva H; Larios G; Verra P; Stamou C; Kontochristopoulos G; Avgerinou G; Katsambas A
Dermatology; 2009; 218(4):338-41. PubMed ID: 19212110
[TBL] [Abstract][Full Text] [Related]
5. Bullous congenital ichthyosiform erythroderma: safe and effective topical treatment with calcipotriol ointment in a child.
Bogenrieder T; Landthaler M; Stolz W
Acta Derm Venereol; 2003; 83(1):52-4. PubMed ID: 12636025
[No Abstract] [Full Text] [Related]
6. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
Kumaran MS; Kaur I; Kumar B
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
[TBL] [Abstract][Full Text] [Related]
7. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
8. Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo.
Newman MD; Silverberg NB
Cutis; 2011 Nov; 88(5):256-9. PubMed ID: 22272490
[TBL] [Abstract][Full Text] [Related]
9. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
10. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment of severe nail psoriasis using topical calcipotriol with betamethasone dipropionate gel.
Tan ES; Oon HH
Indian J Dermatol Venereol Leprol; 2016; 82(3):345-7. PubMed ID: 27088952
[No Abstract] [Full Text] [Related]
12. Update on Topical Treatments for Psoriasis: The Role of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam.
Puig L; Carretero G
Actas Dermosifiliogr (Engl Ed); 2019 Mar; 110(2):115-123. PubMed ID: 30031488
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
14. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
Vissers WH; Berends M; Muys L; van Erp PE; de Jong EM; van de Kerkhof PC
Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
[TBL] [Abstract][Full Text] [Related]
15. Balance of Treg versus T-effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol-betamethasone dipropionate ointment.
Keijsers RR; Joosten I; Hendriks AG; Koenen HJ; van Erp PE; van de Kerkhof PC
Exp Dermatol; 2015 Jan; 24(1):65-7. PubMed ID: 25355140
[TBL] [Abstract][Full Text] [Related]
16. Disseminated epidermolytic acanthoma with partial response to calcipotriol ointment.
Batalla A; Carpintero ML; De la Torre C
J Dermatol; 2013 Feb; 40(2):144-5. PubMed ID: 23083445
[No Abstract] [Full Text] [Related]
17. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K
J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740
[TBL] [Abstract][Full Text] [Related]
18. First case series on the use of calcipotriol-betamethasone dipropionate for morphoea.
Dytoc MT; Kossintseva I; Ting PT
Br J Dermatol; 2007 Sep; 157(3):615-8. PubMed ID: 17553054
[No Abstract] [Full Text] [Related]
19. The effect of combined calcipotriol and betamethasone dipropionate ointment in the treatment of vitiligo: an open, uncontrolled trial.
Xing C; Xu A
J Drugs Dermatol; 2012 Oct; 11(10):e52-4. PubMed ID: 23135000
[TBL] [Abstract][Full Text] [Related]
20. Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference.
Sandoval LF; Huang KE; Harrison J; Clark A; Feldman SR
Cutis; 2014 Dec; 94(6):304-9. PubMed ID: 25566573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]